UBS Group’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9K | Buy |
13,972
+3,851
| +38% | +$7.97K | ﹤0.01% | 6884 |
|
|
2025
Q1 | $17K | Sell |
10,121
-4,087
| -29% | -$6.87K | ﹤0.01% | 7030 |
|
|
2024
Q4 | $31.3K | Buy |
14,208
+8,062
| +131% | +$17.7K | ﹤0.01% | 6347 |
|
|
2024
Q3 | $9.16K | Buy |
6,146
+2,992
| +95% | +$4.46K | ﹤0.01% | 6590 |
|
|
2024
Q2 | $6.25K | Sell |
3,154
-2,104
| -40% | -$4.17K | ﹤0.01% | 6777 |
|
|
2024
Q1 | $16.1K | Buy |
5,258
+2,630
| +100% | +$8.07K | ﹤0.01% | 5846 |
|
|
2023
Q4 | $18.2K | Buy |
+2,628
| New | +$18.2K | ﹤0.01% | 5957 |
|
|
2023
Q2 | – | Sell |
-2,301
| Closed | -$4.19K | – | 8076 |
|
|
2023
Q1 | $4.19K | Sell |
2,301
-2,386
| -51% | -$4.34K | ﹤0.01% | 7123 |
|
|
2022
Q4 | $10.7K | Sell |
4,687
-7,317
| -61% | -$16.8K | ﹤0.01% | 7280 |
|
|
2022
Q3 | $16K | Buy |
12,004
+7,667
| +177% | +$10.2K | ﹤0.01% | 6594 |
|
|
2022
Q2 | $11K | Buy |
+4,337
| New | +$11K | ﹤0.01% | 6773 |
|
|
2022
Q1 | – | Sell |
-32,649
| Closed | -$116K | – | 9357 |
|
|
2021
Q4 | $116K | Buy |
+32,649
| New | +$116K | ﹤0.01% | 5111 |
|